India · Delayed Price · Currency is INR Medico Remedies Statistics
Total Valuation
Medico Remedies has a market cap or net worth of INR 3.22 billion. The enterprise value is 3.34 billion.
| Market Cap | 3.22B |
| Enterprise Value | 3.34B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 82.98M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.22% |
| Shares Change (QoQ) | -0.99% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 17.69M |
Valuation Ratios
The trailing PE ratio is 31.16.
| PE Ratio | 31.16 |
| Forward PE | n/a |
| PS Ratio | 2.03 |
| PB Ratio | 5.15 |
| P/TBV Ratio | 5.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 32.34 |
| EV / Sales | 2.11 |
| EV / EBITDA | 22.31 |
| EV / EBIT | 27.91 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 0.98 |
| Debt / FCF | n/a |
| Interest Coverage | 12.48 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.88% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 7.44M |
| Profits Per Employee | 485,099 |
| Employee Count | 213 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Medico Remedies has paid 34.30 million in taxes.
| Income Tax | 34.30M |
| Effective Tax Rate | 24.92% |
Stock Price Statistics
The stock price has decreased by -14.81% in the last 52 weeks. The beta is 0.03, so Medico Remedies's price volatility has been lower than the market average.
| Beta (5Y) | 0.03 |
| 52-Week Price Change | -14.81% |
| 50-Day Moving Average | 39.88 |
| 200-Day Moving Average | 52.13 |
| Relative Strength Index (RSI) | 45.23 |
| Average Volume (20 Days) | 189,693 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medico Remedies had revenue of INR 1.58 billion and earned 103.33 million in profits. Earnings per share was 1.25.
| Revenue | 1.58B |
| Gross Profit | 428.71M |
| Operating Income | 119.71M |
| Pretax Income | 137.63M |
| Net Income | 103.33M |
| EBITDA | 145.61M |
| EBIT | 119.71M |
| Earnings Per Share (EPS) | 1.25 |
Balance Sheet
The company has 25.46 million in cash and 147.00 million in debt, giving a net cash position of -121.54 million.
| Cash & Cash Equivalents | 25.46M |
| Total Debt | 147.00M |
| Net Cash | -121.54M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 624.69M |
| Book Value Per Share | 7.53 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 27.07%, with operating and profit margins of 7.56% and 6.52%.
| Gross Margin | 27.07% |
| Operating Margin | 7.56% |
| Pretax Margin | 8.69% |
| Profit Margin | 6.52% |
| EBITDA Margin | 9.19% |
| EBIT Margin | 7.56% |
| FCF Margin | n/a |
Dividends & Yields
Medico Remedies does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.22% |
| Shareholder Yield | n/a |
| Earnings Yield | 3.21% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 16, 2023. It was a forward split with a ratio of 5.
| Last Split Date | Mar 16, 2023 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |